Impact - The Jimmy Fund

Impact 

SUMMER 2008 

dana-farber.org and jimmyfund.org 

THANKING THOSE WHO MAKE A DIFFERENCE. 

Volume 11 • Issue 3 

Cycling in solidarity: PMC riders raise 

projected $34 million 

3 

Terrific 

Tournaments 

For most people, a bike ride means a challenging 

workout and the chance to have a little fun. For the 

more than 5,500 riders in the 2008 Pan-Massachusetts 

Challenge (PMC), it entailed much more: the opportunity 

to change the future for cancer patients by raising critical 

funds for groundbreaking research and innovative cancer care 

programs at Dana-Farber Cancer Institute. 

Buoyed by the PMC’s presenting co-sponsors, the Red 

Sox Foundation and Overstock.com, along with 200 in-kind 

sponsors and more than 2,600 volunteers who manned food 

and water stations among other tasks, riders covered up to 190 

miles Aug. 2 and 3. They rode despite the challenges of the heat 

and occasional summer storms of a New England August and 

the demanding hills peppering the route. Their smiling faces 

reflected triumph and accomplishment as they crossed the finish 

continued on page 7 

5 

Flavorful 

Festival 

7 

Wheel 

Winners 

13 

Sox 

Support 

15 

Proud 

Patrons 

Ready to ride: More than 5,500 cyclists from 36 states and eight countries participated in the 29th annual Pan-Massachusetts Challenge. 

Everyone wins during Stop & Shop Triple Winner promotion 

From April through July, store customers across the Northeast stepped up 

to participate in the Stop & Shop Supermarket Company’s Triple Winner 

Game, a scratch ticket promotion benefiting Dana-Farber’s fight against 

pediatric brain tumors and the late effects of treatment. Purchased for $1 each, the 

tickets offered participants the potential to instantly win free items, coupons, gift 

cards, or cash prizes of up to $10,000. Game players could also double their luck 

with the program’s 2nd Chance Sweepstakes, in which previously scratched tickets 

were entered into a drawing for unclaimed prizes of more than $500. 

This combination of philanthropy and fun once again proved irresistible to 

customers, who contributed more than $2.5 million toward both the Stop & Shop 

Family Pediatric Brain Tumor Clinic and Stop & Shop Pediatric Neuro-Oncology 

“By supporting cancer care and research initiatives at 

Dana-Farber, we all look forward to bringing about the 

day when this terrible disease is a distant memory.” 

— Institute Trustee Jose Alvarez 

Outcomes Clinic. Since 1991, the Triple Winner Game, which is co-sponsored 

by the Boston Red Sox, has cumulatively raised more than $40 million for these 

world-renowned clinics. 

“Stop & Shop and its generous customers, dedicated associates, suppliers, and 

distributors have a long and proud tradition of philanthropy and service to the 

community that I am thrilled to continue,” said Institute Trustee Jose Alvarez, an 

executive at Ahold, Stop & Shop’s parent company. “By supporting cancer care 

and research initiatives at Dana-Farber, we all look forward to bringing about the 

day when this terrible disease is a distant memory.” 

Advancing treatments while improving cure rates 

Founded in 1997, the Stop & Shop Family Pediatric Brain Tumor Clinic is part 

of the largest pediatric brain and spinal cord tumor program in New England 

and is recognized as one of the most comprehensive pediatric brain cancer centers 

in the world. This program brings together multidisciplinary specialists from 

Dana-Farber and Children’s Hospital Boston to deliver the most effective treatments 

continued on page 9

Giving is easy when you visit us online at dana-farber.org/give. 

Dear Friends, 

This May, Dana-Farber Cancer Institute celebrated 

the 60th anniversary of the Jimmy Fund and 

the enormous impact that this community of 

supporters has had on the fight against cancer 

over the years. In 1948, pediatric cancers were 

almost universally fatal. Today the survival rate 

is 75 percent, and as high as 90 percent for some 

forms of the disease. Adult survival rates also continue to rise thanks to 

breakthroughs such as the recently developed “smart” drug, Gleevec®. Gifts 

to the Jimmy Fund have helped to make these positive statistics possible. 

It is this consistent stream of support that propels new generations of 

bold research endeavors, such as the creation of a cancer-signaling roadmap, 

as well as innovative patient care initiatives like the Sibling Program, both 

of which carry the potential to improve quality of life for our patients and 

their families. 

In this issue of Impact, we highlight these advances and the generosity 

of the event participants, corporate sponsors, volunteers, and individual 

friends who make them possible. 

One such example is the Pan-Massachusetts Challenge, which once 

again displayed its enormous commitment to accelerating the Institute’s 

mission as more than 5,500 cyclists, 2,600 volunteers, and numerous 

sponsor organizations worked together to help the bike-a-thon raise an 

anticipated $34 million for the Jimmy Fund. We thank each and every one 

of them for their incredible energy and dedication to this wonderful event! 

Many of you showed your support in the supermarket aisles at 

Stop & Shop this spring and summer by participating in the Triple Winner 

Game program. This long-running promotion benefits Dana-Farber’s Stop 

& Shop Family Pediatric Brain Tumor Clinic and the Stop & Shop Family 

Pediatric Neuro-Oncology Outcomes Clinic. With more than two million 

customers raising $2.5 million, Stop & Shop Supermarket Company 

exemplifies the impact that a corporate sponsor can have in the fight 

against cancer. 

As a volunteer organization, the Friends of Dana-Farber Cancer Institute 

has made an incredible commitment to our lifesaving mission for more 

than 30 years. We are delighted by this year’s signature fundraiser “Surprise 

Party,” held May 30, which resulted in over 400 people enjoying an evening 

of surprises and raising a wonderful $1 million to fuel groundbreaking 

research, clinical trials, and to support community outreach programs at 

Dana-Farber. 

Demonstrating the value of individual support, Steven and Michele 

Kirsch’s terrific $1 million gift not only bolsters the work of Irene Ghobrial, 

MD, who is making critical research advancements in Waldenström’s 

macroglobulinemia, but also supports our $1 billion goal for Mission 

Possible: The Dana-Farber Campaign to Conquer Cancer. The Kirsches’ 

generosity highlights the absolute necessity of private philanthropy to 

further research in specific disease areas, and we thank them for working to 

change the outlook for those suffering from this rare disease. 

These are just a few of the numerous ways in which our loyal community 

is helping to strengthen our future and build upon our momentum to 

conquer cancer. And for that, we thank you all. 

Sincerely, 

Susan S. Paresky 

Senior Vice President for Development 

Siblings coping with cancer 

aided by foundation grant 

When a child is diagnosed with cancer, his or her entire family often 

struggles to cope with this new reality. Dana-Farber’s Sibling Program 

provides critical support to brothers and sisters of cancer patients 

whose daily lives are often heavily affected by their siblings’ diagnosis and 

treatment, leaving them prone to depression, anxiety, and school-related problems. 

Recognizing the importance of this landmark psychosocial initiative, which 

received seed funding through the Friends of Dana-Farber Cancer Institute 

for several years, the Lawrence J. and Anne Rubenstein Charitable Foundation 

recently gave $261,000 to expand and enhance the program. 

“This grant will provide additional services, including education, counseling, 

and special activities, all of which will help ease the stress these children often 

face,” said Foundation Trustee Steven Perlmutter, also a Dana-Farber trustee. 

The Rubenstein Foundation’s grant will enable siblings of young cancer patients to receive critical 

emotional and psychological support as they cope with their brother’s or sister’s diagnosis. 

A part of DFCI’s Division of Pediatric Psychosocial Services, the Sibling 

Program—which is considered a national model for similar programs across the 

country—provides psychosocial support to a sibling from the beginning of his 

or her brother’s or sister’s diagnosis, continuing through either survivorship or 

bereavement. These services include psychological and emotional assessments, as 

well as events and activities in which the children can interact with others facing 

similar situations. 

Research has shown that the stress levels in siblings of cancer patients is often 

equal to that of the ill child, and activities that foster bonding among these 

siblings help to reduce stress and other emotional and social issues. 

“This grant provides a solid, critical base for the program to expand and reach 

even more individuals,” said Deborah Bond Berk, LICSW, coordinator of the 

Sibling Program. “These children, whose lives are turned upside down, will be 

completely supported through the generosity of the Rubenstein Foundation.” 

Added DFCI’s Chief of Staff Stephen E. Sallan, MD, “It’s my pleasure to 

express the Institute’s long-term support for our Sibling Program, an initiative that 

poignantly represents Dana-Farber’s patient-family centered care mission.”n 

Help Dana-Farber make 

its mission possible 

Be a part of Dana-Farber’s campaign to conquer cancer. Contact 

Julia Parrillo, Assistant Vice President, Campaign and Development, 

at 617-632-6573 or julia_parrillo@dfci.harvard.edu to learn how. 

dana-farber.org/campaign 

Golfers primed to notch another hole in one 

Jimmy Fund Golf charged into its 26th year with the same drive that made 

last season a landmark year for fundraising. By the end of July, the program’s 

dedicated tournament organizers, volunteers, and participants had already 

raised $3.1 million toward its more than $7 million goal in support of research 

and patient care initiatives at Dana-Farber. 

Left to right: Tournament Co-chairs Stuart and Maxine Rosenthal, Matt Langweber, Ellie Svenson, Karen 

Langweber, Laraine Levy, and Helene and Mark Lapman celebrate the success of the John R. Svenson Classic. 

On June 2, the John R. Svenson Classic, a new addition to Jimmy Fund Golf 

in 2008, advanced DFCI’s crusade against cancer by raising $250,000. Held at the 

Belmont Country Club in Belmont, Mass., the tournament honored the memory of 

John R. Svenson, a founder of the real estate development company the Abbey Group 

and co-owner of the Boston Celtics, who succumbed to cancer in July 2007. 

“John was extremely generous and always emphasized the importance of giving 

back to others,” said Svenson’s wife, Ellie. “This tournament serves as a means for 

us to remember him while passing on his message.” 

Golfers also gave their time and energy at the 22nd annual Mark R. Ungerer 

Driving for the Cure Memorial Golf Tournament, held July 13 and 14 at The 

International in Bolton, Mass. This year’s tournament, co-chaired by Jim Coghlin 

Sr. and Tom Mack and coordinated by Susan Cyr, tallied nearly $530,000, which 

is earmarked to support cancer research for adolescent and young adult patients 

between the ages of 15 and 40. The event also celebrated the lives of the late Mark 

R. Ungerer, one of three original organizers of the tournament, and his son, David, 

who also passed away from cancer. 

“ Running a tournament allows you to get to know your 

colleagues and business partners outside of your normal 

business practice. It’s also a great team-building experience. 

The satisfaction you get when you hand over a check to 

such a worthwhile organization for such a great cause is 

unparalleled. It’s an incredibly rewarding experience.” 

— MICHAEL MCKNIGHT 

Vice President of Construction, Stop & Shop 

Stop & Shop Donovan/Carlson Jimmy Fund Golf Classic 

Launched in 1992 

On June 23, golfers took to the fairways to fight leukemia at the Kristin Fund 

Leukemia Foundation Golf Tournament. Held at the Oak Hill Country Club 

in Fitchburg, Mass., the tournament raised more than $100,000 in support of 

Richard Stone, MD, director of the Adult Acute Leukemia Program at DFCI, 

while paying tribute to Kristin Amico Sesselman, who passed away from leukemia 

in July 2000. 

A day of triumphs 

Three tournaments made another tremendous impact in Dana-Farber’s fight 

against cancer by collectively raising an astounding $875,000 in one day. 

On June 16, the 29th annual Jimmy Fund Golf Tournament/Jeffrey Vinick 

Memorial contributed to the momentum by tallying more than $500,000. 

Coordinated by the Jimmy Fund Council of Western Massachusetts and a 

committee of more than 50 

key Dana-Farber supporters, 

including Institute Trustees 

Barbara and James Sadowsky, 

the event was played on five 

separate courses across Western 

Massachusetts and Connecticut. 

The Jimmy Fund Players 

Tournament, hosted by Institute 

Trustees Paul Severino, Mike 

Champa, and Jim Dow, carried 

the momentum, bringing in 

more than $200,000 for DFCI’s 

High-Tech Multidisciplinary 

Research Fund, which 

provides scientists with access 

to sophisticated technology 

that increases the speed and Tom Mack (left) and Jim Coghlin Sr. served as co-chairs at the 22nd 

annual Mark R. Ungerer Driving for the Cure Memorial Golf Tournament. 

accuracy of their work. 

At the Black Rock Country 

Club in Hingham, Mass., the Jimmy Fund Council of Greater Boston’s Jimmy 

Fund/UGL-Unicco Golf & Tennis Classic drove it all home by raising more than 

$150,000 to further the Institute’s lifesaving mission. 

With solid efforts through its season’s midway point, Jimmy Fund Golf is 

poised to score yet another record-breaking year in its storied history. 

“Our tournament directors and volunteers and their dedication and 

commitment were truly the driving force behind this strong start,” said Jimmy 

Fund Golf Director Nancy Rowe. “Their compassion for others and love of the 

game is making a difference in the lives of cancer patients everywhere.”n 

MAKE BEATING CANCER 

YOUR BUSINESS 

Start a corporate Jimmy Fund Golf tournament. 

Expand your business network, reward your employees, and make new contacts. 

Visit jimmyfundgolf.org or contact Tim Barry at 866-521-GOLF. 

Impact SUMMER 2008 

Volume 11 • Issue 3 

This issue covers gifts received and finalized through 

the spring and summer of 2008. 

Impact, a newsletter of Dana-Farber Cancer Institute and the Jimmy 

Fund, is published by the Division of Development in collaboration 

with the Department of Communications for friends and supporters 

of Dana-Farber and the Jimmy Fund. 

President, Dana-Farber Cancer Institute Edward J. Benz Jr., MD 

Chief of Staff Stephen E. Sallan, MD 

Chief Medical Officer Lawrence Shulman, MD 

Chief Scientific Officer Barrett J. Rollins, MD, PhD 

Chief Clinical Research Officer Philip W. Kantoff, MD 

Chair of Medical Oncology James Griffin, MD 

Chair of Pediatric Oncology Stuart H. Orkin, MD 

Chair of Radiation Oncology Jay R. Harris, MD 

Chair of Executive Committee for Research David M. Livingston, MD 

Senior Vice President for Experimental Medicine Lee M. Nadler, MD 

Senior Vice President for Patient Care Services, Chief Nurse 

Patricia Reid Ponte, RN, DNSc, FAAN 

Senior Vice President for Research Beverly R. Ginsburg-Cooper, MBA 

Senior Vice President for Development Susan S. Paresky 

Chairman of the Jimmy Fund Michael J. Andrews 

Senior Vice President for Communications Steven R. Singer 

Impact Editor Brian Geer 

Assistant Editor Lauren Carr 

Contributors Tiffany Amoakohene, Amy Barberie, Jared Berezin, 

Courtney Blenheim, Elizabeth Chernack, David Ferreira, Kristin 

Lacey, Daniel Morris, Liz Nelson, Robin Orwant, Patrick Rooney, 

Diane Schmidt, Sharon Veino, Coral Vogel, Lindsay Wilber 

Art Director Alan Caplan 

Designer Beth Rossi 

Production Coordinator Georgina Morales Hampe 

Photographers Lisa Cohen, Phill Davis, Nikki Dedekian, John 

Deputy, Steve Gilbert, Channing Johnson, Raffi Kebabjian, Justin 

Knight, Zeff Nikolla, Sam Ogden, Jill Person, Philip Porcella, Rose 

Raymond, Len Rubenstein, Richard Schultz, Aaron Washington 

To request a copy of Impact or to be removed from our mailing list, 

please contact: 

DFCI Development Office 

10 Brookline Place West, 6th Floor 

Brookline, MA 02445-7226 

617-632-3019 or 800-52-JIMMY 

or download an issue at dana-farber.org/impact. 

Dana-Farber Cancer Institute provides expert, compassionate care 

to children and adults and is home to groundbreaking cancer 

discoveries. Since its founding in 1948, the Jimmy Fund has raised 

millions of dollars through thousands of community efforts to 

advance Dana-Farber’s lifesaving mission. 

Runners’ 10K milestone honored 

During its annual “10K Team” reception, held June 11 at Dana-Farber Cancer Institute, 

the 2008 Dana-Farber Marathon Challenge (DFMC) recognized the efforts of its 100 top 

team fundraisers (right) who each ran 26.2 miles in this year’s Boston Marathon ® and 

raised $10,000 or more. 

To date, this pacesetting group has collected a combined $1.6 million from their April 

run—nearly 40 percent of the $4.5 million goal for this year’s entire 550-person DFMC 

team. Every dollar raised by team members supports the Claudia Adams Barr Program in 

Innovative Basic Cancer Research at DFCI and its researchers’ efforts to unlock the basic 

mysteries of cancer. 

2 Impact SUMMER 2008 

Impact SUMMER 2008 3

Courageous patient adds 

visibility to Head and Neck 

Oncology Program 

When Robert Malloy was diagnosed with neck cancer in 2006, his 

primary care physician referred him to Marshall Posner, MD, director 

of Dana-Farber’s Head and Neck Oncology Program. Thanks to 

Posner’s expert care, the former vice 

president of Institutional Sales for 

Merrill Lynch is now enjoying his 

retirement cancer-free. 

“The people at Dana-Farber 

made my treatment a more tolerable 

experience,” said Malloy. “It’s not 

just about the skilled doctors but also 

about the personality and treatment 

of individuals like my chemotherapy 

nurse, who always made me feel like 

everything would be OK,” said Malloy. 

In gratitude, Malloy and his wife 

recently gave $100,000 to establish the 

Rita and Robert Malloy Fund for Head 

and Neck Cancer Research, which will 

The Malloys’ gift will fund critical, additional staff for help Posner and his team conduct more 

Dana-Farber’s Head and Neck Oncology Program, 

clinical trials. This gift also supports 

led by Director Marshall Posner, MD. 

Mission Possible: The Dana-Farber 

Campaign to Conquer Cancer. 

A laryngectomy and chemoradiotherapy, the common method of neck cancer 

treatment for Malloy’s cancer, has only a 15 percent cure rate. However, DFCIdeveloped 

treatments have increased the cure rate to 60 to 70 percent. Malloy, 

who was treated for very advanced neck cancer, was the first person at Dana- 

Farber to participate in an experimental clinical trial conducted by Posner, 

which included a four-drug regimen of targeted therapy and taxotere-cisplatinfluorouracil 

(TPF) combined with chemoradiotherapy. 

“We are thrilled to find private donor support that allows us to conduct these 

trials,” said Posner. “Robert Malloy’s bravery and generosity will enable Dana- 

Farber to advance cutting-edge therapy for head and neck cancer patients through 

clinical trials and clinical research that pharmaceutical companies generally 

consider too risky to fund.” n 

Run in any race, of any distance, in any city. 

Learn more at Jimmyfund.org/race or call 617-632-1970. 

Sadowsky family dedicated 

to defeating lymphoma 

Ronald and Brenna Sadowsky and their family have been touched by cancer 

in many ways. Despite their difficult personal experiences with the disease, 

they are grateful to have been introduced to Dana-Farber’s first-class care. 

In honor of their connection to the Institute and their faith in its lifesaving 

mission, the Sadowskys have given $100,000 to support research into 

lymphoma, a type of cancer that has affected two family members. 

“We give to what we believe in, and we have the utmost confidence in Dana- 

Farber,” said Ronald Sadowsky. 

Led by Arnold Freedman, MD, 

of Hematologic Malignancies, the 

Sadowskys’ gift will enable DFCI’s 

Lymphoma Program to conduct 

clinical research into novel drugs. 

“Over the past decade, 

there has been tremendous 

progress in the understanding of 

lymphoma, which has fostered 

the development of more specific 

treatments going after the 

malignant cells, with a goal of 

lower toxicity,” said Freedman. “At 

the same time, support for basic 

research has exceeded funding for 

clinical research, making the latter 

a critical priority.” 

In the next year, the program 

will offer several new clinical 

trials testing drugs that are 

highly specific for subtypes of 

lymphoma. Both the Sadowskys 

and Freedman hope that these 

trials will translate into 

lives saved. n 

Brenna and Ronald Sadowsky (center) and their sons (from left) 

Drew, Jace, and Ross have participated in numerous Jimmy Fund 

events, including the annual Jimmy Fund Golf Tournament/Jeffrey 

Vinick Memorial. 

Making a splash for Dana-Farber 

Mutual Funds Against Cancer scores ace for cancer research 

on and off the links 

More than 400 golfers enjoyed a day on the links at the 14th annual 

Mutual Funds Against Cancer (MFAC) Expect Miracles Golf Classic. 

Held June 12 at three different courses in Plymouth, Mass., this annual 

tournament raised more than $600,000 for the Center for Applied Cancer Science 

(CACS) at Dana-Farber. 

MFAC began when founder Frank Strauss’ mother, Sandra, was diagnosed with 

leukemia and treated successfully at the Institute. While visiting her, Frank could 

not help but notice the compassionate treatment and care DFCI patients received 

and was inspired to raise funds. 

In response, he organized a friends and family golf outing, in which 48 

participants raised $6,000 for Dana-Farber. Since then, the tournament has grown 

exponentially, raising more than $2.5 million since its inception and attracting top 

financial firms as sponsors, including Interactive Data Corp., State Street Corp., 

JPMorgan Chase & Co., and Citi, to name a few. 

“At the time of my mother’s diagnosis, I felt that being in the financial industry 

meant that I might be in the right place to bring people together for this cause,” 

said Strauss, now MFAC chairman. “The industry has really embraced us, helping 

raise awareness about the need for funds to fight the war on cancer.” 

Aside from its financial success —including maintaining an annual growth rate 

in excess of 50 percent—MFAC has enjoyed other notable achievements, such 

as being selected to ring the opening bell at the New York Stock Exchange and 

being honored as “selected charity of the year” for a second year in a row at the 

Institutional Investors’ Mutual Funds Award Gala in 2008. 

Driving drug discovery 

Over the past year, Mutual Funds Against Cancer has directed its giving to 

specifically support CACS. Established in 2004, the center is dedicated to 

discovering cancer genes within tumors and translating this information into 

new treatments. Researchers focus their studies on six cancers that together cause 

approximately 60 percent of the cancer deaths in industrialized nations: brain, 

colon, lung, melanoma, myeloma, and pancreatic cancers. 

Through the mapping of the human genome, CACS researchers have developed 

Jimmy Fund celebrates “scooper” success 

A 

record-breaking 8,000 gallons of ice cream were served up this year 

at the 26th annual Jimmy Fund Scooper Bowl® presented by FedEx, 

raising a cool $350,000 for the Jimmy Fund. During the nation’s largest 

all-you-can-eat ice cream festival, tens of thousands of scoops were enjoyed by 

businesspeople, school groups, and families, who flocked to Boston’s City Hall 

Plaza to participate in the three-day event held June 10-12. 

The fun-filled festivities featured more than 40 flavors of ice cream, frozen 

yogurt, sorbet, and gelato from 10 of the nation’s leading vendors. Boston 

Mayor Thomas M. Menino, the Boston Red Sox wives, and members of the 

Boston Cannons lacrosse team all made special appearances during the event. 

Musical entertainment from Michael Bouche, local band Clarias, the Friends 

of Broadway, Evan Michael, and the brother and sister rock duo Michael and 

Marisa delighted attendees as they enjoyed their frosty treats. 

On Wednesday evening, the Scooper Bowl debuted “The Metro’s Nighttime 

Scoop,” catering to the after-work crowd. Local cover band Heart of Boston 

served up fun tunes for the ice cream-loving audience. 

“The Jimmy Fund Scooper Bowl is truly an event that everyone can enjoy— 

families, adults, and kids,” said Jimmy Fund Chairman Mike Andrews. “This 

year was a success thanks to everyone who came out to enjoy a delicious dessert 

for a good cause.” n 

Mutual Funds Against Cancer Chairman Frank Strauss (front row, center) stands with MFAC’s board of 

directors and the Red Sox 2004 and 2007 World Series Trophies at the Expect Miracles Golf Classic June 12. 

a more complete atlas of mutated genes that drive these cancers. 

“The challenge now is to identify those mutations that are essential for the 

maintenance of the tumors,” said CACS Director Ronald DePinho, MD. “Drugs 

targeting these events are likely to be more highly effective than previous cancer 

therapies, in which only one out of every 20 such drugs would receive FDA 

approval. MFAC’s funding has helped us to make the cancer drug discovery 

process less costly and more efficient.” 

Explained Strauss, “We chose to support the CACS not only because we 

wanted to show our supporters tangible results from the money raised, but also 

because we were very excited about Dr. DePinho. We are confident that these 

funds will allow him and his team to revolutionize cancer treatment.” n 

Ketsia Vdrine (left) and Tamara Robert beat the heat with frozen scoops at the 26th annual Jimmy Fund 

Scooper Bowl ® . 

Hundreds of swimmers donned their caps, goggles, and wetsuits this summer for 

the 13th annual Boston Harbor Island Swim to benefit the David B. Perini, Jr. Quality 

of Life Clinic at Dana-Farber. Held July 11, the exciting 22-mile relay race began 

and finished at Rowe’s Wharf in downtown Boston. The following day, a half-mile 

recreational Nantasket Beach Swim took place in Hull, Mass., where swimmers of all 

ages took to the chilly Atlantic to help raise funds for the Perini Clinic’s dual mission of 

caring for survivors of pediatric or adolescent cancers and mitigating the late effects 

of treatments. Above: Swimmers dive into the waters of Boston Harbor to raise nearly 

$300,000 for Dana-Farber. 

A picture can say a thousand words. 

Our pictures may save thousands of lives. 

Commemorate your fun-filled Jimmy Fund or Dana-Farber event experience 

with photos, now available online. Order high-quality prints and specialty items, 

including mousepads, mugs, and more! 

Visit jimmyfundpictures.org today. 



Learn more about the Mission Possible Campaign at dana-farber.org/campaign. 

Renowned philanthropist’s newest cause hits close to home 

PMC continued from page 1 

For more than a decade, Steven Kirsch has given tens of millions of dollars 

to support medical research, education, environmental protection, and 

community-based charities. Committed to making the greatest possible 

impact with his gifts, he has always placed a premium on finding and supporting 

underfunded yet worthwhile 

projects. In August 2007, he found 

just such a cause in Waldenström’s 

macroglobulinemia—only this time, 

it was personal. 

“I had never heard of 

Waldenström’s before I was 

diagnosed with it,” he said. “I had 

to crack open the textbooks and do 

some research.” 

Kirsch was appalled to learn the 

deadly blood cancer receives almost 

no attention from government 

funding agencies or pharmaceutical 

companies because it is relatively 

rare. Scarce funding means few 

scientists study this “orphan” 

disease and, therefore, relatively few 

treatment options exist for patients. 

Determined to change that, 

Kirsch began a nationwide search 

for the most promising researchers 

in the field. He quickly decided 

on the only center in the world 

Michele and Steven Kirsch hope their support of Waldenström’s 

macroglobulinemia research will produce lifesaving treatments 

for patients with this rare disease. 

The good fight 

focused specifically on this disease: 

Dana-Farber’s Bing Center for 

The community of Middleton, Mass., came together to honor one of their own with 

Jack Fights Back, an inaugural event to raise funds for neuroblastoma research at 

Dana-Farber. Held April 6 at the Danversport Yacht Club in Danvers, Mass., the benefit 

was organized by Ron and Kim Supino, whose 9-year-old son Jack has successfully 

battled this cancer of the nervous system. 

Originally expecting a modest turnout, the Supinos were moved by the mass of neighbors 

and friends who attended, as well as local businesses that contributed more than 

70 items for the raffle and silent auction. At the end of the day, this swell of support 

carried Jack Fights Back to a fundraising total of more than $100,000—four times 

more than initial expectations. 

According to the family, no one was happier with the outcome than Jack himself 

(above), who, at one point during the event, took center stage for an impromptu 

performance of Elvis Presley’s “Jailhouse Rock.” 

Waldenström’s Macroglobulinemia. Impressed by what he saw, Kirsch and his 

wife, Michele, have given Dana-Farber $1 million to support the work of Irene 

Ghobrial, MD, in the Bing Center. 

In recognition of the Kirsches’ generosity, Ghobrial’s laboratory within the 

Bing Center has been named the Michele and Steven Kirsch Laboratory for 

Waldenström’s Research. 

The gift also represents an important contribution to Mission Possible: The 

Dana-Farber Campaign to Conquer Cancer. 

A two-pronged attack 

When deciding which specific projects to fund, Kirsch was particularly drawn 

to Ghobrial’s work. One of the greatest obstacles in combating the disease is the 

ability of Waldenström’s macroglobulinemia cells to hide out in a patient’s bone 

marrow where they are protected from drugs designed to destroy them. Much of 

Ghobrial’s research focuses both on understanding how the cancer cells gain entry 

into the bone marrow and identifying drugs to force them out of their hiding 

places. Using such drugs, she hopes to first “smoke out” the cancer cells and then 

kill them with other treatments. 

“It’s a nice one-two combination,” said Kirsch. “The approach she’s taking 

appears the most promising to me.” 

In addition to supporting clinical trials based on this strategy, the Kirsch gift 

will fuel studies designed to help researchers better understand the basic biology 

of the disease and the causes of its progression. It will also fund projects aimed at 

identifying new drug targets and transforming that knowledge into novel therapies 

as quickly as possible. 

Without the Kirsches’ crucial support, many of these promising endeavors 

would never get off the ground. 

“The government doesn’t usually give much money for Waldenström’s 

macroglobulinemia research,” said Ghobrial. “This gift is huge in terms of helping 

me push our research forward.” n 

Bailey gift zeroes in on genetic 

roots of rare blood cancer 

When Robert “Bob” Bailey was first 

diagnosed with Waldenström’s 

macroglobulinemia in 1997, few 

treatments existed for this unusual illness. In the 

decade that followed, his therapeutic options grew, 

thanks in large part to Steven Treon, MD, PhD, 

director of the Bing Center for Waldenström’s 

Macroglobulinemia at Dana-Farber. 

“Dr. Treon has done so much for people with 

this disease,” said Bailey’s wife, Laura. “Because 

of him, there are now treatments that we never 

would have thought possible 10 years ago.” 

Hoping to build on that success, the Baileys 

have given Dana-Farber $750,000 to fund 

Treon’s research into the genetics of the rare 

blood cancer. 

In previous studies, Treon and his colleagues 

identified Waldenström’s patients with a family 

history of blood cell abnormalities. This subset 

of patients may have inherited genetic risk 

Robert “Bob” Bailey’s positive experience as a 

Dana-Farber patient inspired him and his wife, 

Laura, to support Waldenström’s macroglobulinemia 

research under the direction of Steven Treon, 

MD, PhD (above). 

factors that contribute to the development of the disease. With support from the 

Bailey Family Fund, Treon plans to study these patients and their families in the 

hopes of identifying specific genes underlying the illness—information that might 

yield important clues about what causes the cancer and how to treat 

it more effectively. 

“Research on this rare disease is chronically underfunded,” said Treon. 

“Without the generous support of people like the Baileys, important projects of 

this kind might never move ahead.” 

Research and care are major funding priorities of Mission Possible: The Dana- 

Farber Campaign to Conquer Cancer, and Bailey’s gift supports this 

$1 billion fundraising initiative. 

Bob Bailey’s survival 11 years after diagnosis is a testament to the power 

of DFCI’s ability to rapidly translate discoveries into new therapies to benefit 

patients. Already having lived longer than most people with his disease, he believes 

the development of new therapies has been crucial in helping him beat the odds. 

With this gift, the Baileys hope Treon will one day produce even better treatments, 

improving the odds for all Waldenström’s macroglobulinemia patients. 

“Obviously, we’re interested in helping a lot of people with this disease,” said 

Bob Bailey. “Dr. Treon is the right person, doing the right research, right now.” n 

line to collectively raise an anticipated, record-breaking $34 million. 

The PMC, founded in 1980 by Executive Director and Institute Trustee Billy 

Starr, is the largest athletic fundraising event in the nation. It is so well known 

that it now draws people from 36 states and eight countries who want to make a 

difference in the lives of cancer patients around the globe. 

“We at the PMC relish the role we play at Dana-Farber,” said Starr. “We feel 

challenged, but capable, of providing this incredible annual gift and, at the same 

time, challenged and flattered to find the room for all who want to participate in 

this amazing weekend event.” 

Thriving and surviving 

Paul Schaye, a devoted extreme-sports athlete and Boston native, has participated 

in the PMC for 10 years. His team, “Paul’s Posse,” has raised more than $712,000 

over the past two years alone. In October 2006, his reason for riding became more 

personal: He was diagnosed with stage IV stomach cancer. 

“In the past, I rode to help raise money for cancer research, but I never 

imagined I would ride as a possible beneficiary of that research,” he said. 

Referring to himself as a “cancer thriver,” Schaye faced his treatment with the 

same positive power he put into all of his athletic challenges. After major surgery 

in November 2007 and with the assistance of the “smart” drug Gleevec®, Paul 

remains disease-free. To celebrate this year, he again made the 190-mile journey 

with his Paul’s Posse teammates by his side. 

“We at the PMC relish the role we play 

at Dana-Farber.” 

— Institute Trustee Billy Starr 

The next generation 

The PMC has rapidly become an event for participants of all ages. Since 1998, the 

PMC Kids Ride Program has offered children between the ages of 3 and 15, as 

well as their parents and neighbors, the opportunity to create individual bike-athons, 

including a short obstacle course for tykes on tricycles and a 26-mile trek 

for teens. 

“Through these mini bike-a-thons, we are teaching children the benefits of 

being active and helping others,” Starr said. “The PMC Kids Ride Program is the 

future of the PMC.” 

In 2008, 30 kids rides were held and are expected to raise $750,000 toward the 

PMC’s impressive $34 million goal. n 

Left to right: Paul’s Posse team leader Paul Schaye celebrates being a “cancer thriver” with fellow 

teammates George Demetri, MD, director of DFCI’s Center for Sarcoma and Bone Oncology, Demetri’s 

daughter, Leah Demetri, and Julie Pokela. 

Cycling toward cancer cures 

More than 300 bicyclists pedaled along four different routes throughout Western 

Massachusetts as part of Katelynn’s Ride. Held June 8, the 8th annual fundraiser, which is 

affiliated with the Pan-Massachusetts Challenge bike-a-thon, raised $165,000 to benefit 

groundbreaking research and treatment at Dana-Farber Cancer Institute. This year’s success 

has helped the program surpass $1 million in cumulative fundraising since its inception. 

Katelynn’s Ride began in 2000 to honor 11-year-old Katelynn Battista, a Jimmy Fund 

Clinic patient who lost her battle against cancer in 1997. Moved by her story, Steve 

Stark, of the United States Postal Service, and radio personalities Dan Williams and Kim 

Zachary of Mix 93.1-FM in Springfield, Mass., organized the event in her memory. 

Right: With his parents, Domenic and Michele Battista, by his side, Luke Battista kicked 

off this year’s festivities by cutting the ribbon at the starting line at Hampshire College in 

Amherst, Mass. 

One PMC cyclist shows his enthusiasm for fighting cancer while pedaling along one of the bike-a-thon’s 

various routes. 

Left to right: NECN television anchor R.D. Sahl speaks with PMC Founder and Executive Director and 

Institute Trustee Billy Starr during the event’s opening ceremonies, which included a check presentation 

from younger riders of the PMC Kids Ride. 



Impact is available online at dana-farber.org/impact. 

Evenings unite and inspire 

Dana-Farber Evenings provide Institute supporters with a unique opportunity to learn 

about groundbreaking research and care initiatives as well as to hear from patients 

about their personal experiences with cancer. This year’s Spring Evenings in New York 

and Boston provided lively forums for many inspirational discussions. 

At the New York Spring Evening, hosted by Institute Trustee Mortimer B. Zuckerman 

and held May 8 at the Harvard Club of New York City, Kris Carr, a DFCI patient whose 

documentary film “Crazy Sexy Cancer” chronicled her journey of healing and selfdiscovery, 

spoke to attendees about the importance of maintaining a strong quality of 

life and healthy living after diagnosis. Her physician, George Demetri, MD, director of 

DFCI’s Center for Sarcoma and Bone Oncology and the Ludwig Center at Dana-Farber/ 

Harvard Cancer Center, emphasized DFCI’s total patient care philosophy and how 

investigators are developing less toxic, targeted therapies for patients. 

Below, (left to right): Zuckerman, Carr, and Demetri visit during the event. 

Later in the season, guests turned out for the Boston Spring Evening, held June 12 at 

The Charles Hotel in Cambridge, Mass. This event, hosted by Institute Trustee Shari 

E. Redstone, featured Kelley Tuthill, a television reporter for WCVB-TV/DT Boston 

and a breast cancer survivor who was treated at DFCI, as well as Tuthill’s physician 

Ann Partridge, MD, MPH, director of DFCI’s Program for Young Women with Breast 

Cancer. Tuthill shared how she and her family dealt with the challenging decisions that 

accompanied her diagnosis and treatments, while Partridge spoke of the exciting breakthroughs 

and trends in breast cancer research happening right now at Dana-Farber. 

Below, (left to right): Redstone, Tuthill, and Partridge share in the Boston Evening’s 

festivities with DFCI President and CEO Edward J. Benz Jr., MD. 

Building support for 

ovarian cancer research 

Every year, the New England Regional Council of Carpenters (NERCC), 

its signatory contractors, and the Carpenters Labor-Management Program 

(CLMP) join with the affiliated First Trade Union Bank (FTUB) to sponsor 

a day of fun and fundraising at the Pinehills Golf Club in Plymouth, Mass. For 

the past 12 years, the group has focused on a specific mission: helping to find cures 

for ovarian cancer. 

Left to right: Tom Flynn, Harry Dow, Mark Erlich, Mike Butler, and Richard Kronish (far right) help raise 

funds which in part support the work of DFCI’s Glenn Dranoff, MD (second from right), through the 

Research Foundation for the Treatment of Ovarian Cancer. 

“You think of construction work as a very male-dominated industry, and 

here we are supporting ovarian cancer,” said Tom Flynn, the political director 

for NERCC and executive director for CLMP. “We’ve always been a very 

philanthropic group, and this is a wonderful way for us to give back to 

the community.” 

Recently, the group gave $100,000 through its Research Foundation for the 

Treatment of Ovarian Cancer to support Dana-Farber’s Glenn Dranoff, MD, and 

his studies into the protein MFG-E8. In animal experiments, Dranoff has shown 

he can improve the effectiveness of certain ovarian cancer treatments by blocking 

the protein; however, transforming such preclinical results into real therapies can 

be challenging. 

“Funding to move discoveries from the laboratory bench to patients is often 

scarce,” said Dranoff. “That’s where this gift is going to have a huge impact.” 

Expediting the development of new therapies is precisely what former FTUB 

Chairman Richard Kronish hopes to accomplish with the gift. 

“Not many women survive ovarian cancer, so we really want to see this research 

move forward,” he said. “Cures can’t come fast enough.” n 

Triple Winner continued from page 1 

and ensure the highest possible functionality and quality of life for each child. 

With more and more children winning their battles against cancer because 

of innovative treatments and novel therapeutics, there is an increased focus on 

enhancing every survivor’s quality of life. In response to this growing population— 

and in recognition of the unique needs of pediatric brain tumor survivors—DFCI 

also used funds generated from the Triple Winner Game to launch the Stop & Shop 

Pediatric Neuro-Oncology Outcomes Clinic in 2003. This center provides children 

and young adults with comprehensive, multidisciplinary medical care and helps 

them cope with the long-term effects of brain tumors and the treatments used to 

fight them. 

“Stop & Shop’s partnership with Dana-Farber has enabled us to build a premier 

program in the research and treatment of pediatric brain tumors,” said Mark Kieran, 

MD, PhD, director of Pediatric Medical Neuro-Oncology at DFCI. “Without their 

steadfast support, the significant advances we have accomplished in cancer biology, 

drug design and delivery, and the care and treatment of children with brain tumors 

would not have been possible.” n 

The Ambrose Monell Foundation 

provides critical seed funding 

The Ambrose Monell Foundation has supported many of the nation’s leading 

scientific, cultural, and educational institutions for more than 50 years. 

For the sixth year in a row, the foundation, recognizing the excellence 

Generous unrestricted support from the Ambrose Monell Foundation provides the Institute with flexible 

funding to be directed where it is needed most, including patient care priorities. 

Fantasy Day scores home 

run for Boston Red Sox fans 

Playing baseball at Fenway 

Park is an experience most 

just dream about, but for 

300 Jimmy Fund and Boston Red 

Sox fans, it became a reality at the 

17th annual Jimmy Fund Fantasy 

Day at Fenway Park in Boston, 

held June 28. 

Participants contributed funds 

to fight cancer in exchange for 

the opportunity to bat, field, and 

run the bases of America’s most 

beloved ballpark. 

Off the field, the Ultimate Fan 

Experience, created in partnership 

with the Red Sox Team Store, 

offered spectators the chance 

to participate in tours, panel 

discussions with baseball experts, 

and several family-friendly 

activities, including batting cages, 

contests, and face painting. 

By the end of the day, the 

Event sponsor and DFCI Trustee Ken Levine stands on deck 

generosity of these sports 

to bat in his 17th Fantasy Day at Fenway Park. 

enthusiasts helped to raise more 

than $500,000 for the Institute’s lifesaving mission. 

For many fans, such as Institute Trustee Ken Levine and his brother, Bob, 

Fantasy Day has become a family tradition. The Levines have participated for 

years in honor of their late brother, Mark, who passed away from leukemia in 

1987, as well as their father, George, who lost his battle with multiple myeloma 

in 2003. 

In 2008, the Levines reaffirmed their commitment to Dana-Farber by 

sponsoring the event. 

“Fantasy Day is an incredible day,” said Ken Levine. “All of us on the field are 

hitting, fielding, and having a blast while fighting for such a great cause.” n 

INTRODUCING 

DANA-FARBER AND THE JIMMY FUND 

E-CARDS 

of Dana-Farber’s cancer research and care, has supported the Institute with an 

unrestricted grant of $100,000. 

“We are extremely grateful for the steadfast support of the Ambrose Monell 

Foundation,” said Institute President and CEO Edward J. Benz Jr., MD. 

“Unrestricted gifts are the lifeblood of the Institute. These flexible funds allow 

us to be nimble and seize important scientific and clinical opportunities as 

they arise.” 

Benz went on to say that gifts like the foundation’s provide DFCI physicians 

and researchers with the resources they need to blaze new trails in discovering and 

developing new and safer treatments for patients. 

“We are deeply honored to be counted among their distinguished grantees 

again this year,” he added. n 

Make an executive decision 

to fight cancer. 

Make a $5 gift to DFCI to send a festive eCard to honor a 

family member, friend, or colleague on a special occasion. 

Brighten someone’s day while supporting our efforts to 

conquer cancer. 

join Jimmy’s 

circle of friends! 

The Dana-Farber President’s Circle recognizes leaders who 

make annual gifts of $1,500 or more. 

To learn more, please call Leigh Janczak at 617-582-7537 

or e-mail leigh_janczak@dfci.harvard.edu. 

To order your eCard, visit jimmyfund.kintera.org/ecards. For more 

information, e-mail Mary Bucci at annual_giving@dfci.harvard.edu. 

Sign up for an account at MySpace.com or Facebook.com, 

the world’s fastest-growing social networking sites, and add 

the Jimmy Fund as your “friend.” You’ll receive updates on 

upcoming events and help us spread the word about our 

lifesaving mission. 

Learn more at 

Myspace.com/jimmyfund48 or 

Facebook.com. 

Get your plate today at: 

jimmyfund.org/soxplate 



Join our MySpace and Facebook communities at Myspace.com/jimmy48 and Facebook.com. 

Endowed fund addresses young adults’ psychosocial needs 

Though survival rates for pediatric and adult cancer patients have risen 

approximately 30 percent over the past two decades, this encouraging trend 

does not encompass the 67,000 individuals ages 15 to 40 who are diagnosed 

with cancer each year. For this 

specific age group, survival rates 

remain unchanged, and cancer is 

still the number one disease-related 

cause of death. To improve this 

prognosis, Dana-Farber launched 

the Adolescent and Young Adult 

(AYA) Oncology Program in 2005. 

“We’ve known little about the 

biology of cancer in young adults,” 

explains Karen Albritton, MD, 

program director. “Our program 

allows scientists to study how cancer 

behaves in these patients, and how 

the disease affects them specifically.” 

A variety of psychosocial issues, 

such as isolation from peers and 

the need to juggle the demands 

of school or work, appear to 

contribute to slow progress in 

improving the outcomes for these 

individuals. After reading about the 

Overseeing the Endowed Fund for Adolescent and 

Young Adult Psychosocial Oncology, DFCI’s Susan 

Block, MD, hopes to improve the quality of life for 

cancer patients ages 15 to 40. 

AYA program in the case statement 

for Mission Possible: The Dana- 

Farber Campaign to Conquer Cancer, 

two anonymous donors have 

Funnyman Carell rolls out the red carpet 

Hollywood shined its spotlight on Boston when actor Steve Carell teamed up with 

Dana-Farber for a special screening of his new movie, “Get Smart.” Held June 19 at the 

Citi Performing Arts Center, Wang Theatre, in association with Warner Bros. Pictures, 

the second annual “A Premiere Cause” event raised $447,000 for the Zachary Carson 

Brain Tumor Fund at DFCI. Created in honor of Zachary “Zach” Carson, who lost his 

battle against diffuse pontine glioma in September 2007, the fund supports the research 

of Carson’s doctor, Mark Kieran, MD, PhD, director of Pediatric Medical Neuro-Oncology 

at Dana-Farber. 

At right (left to right): Prior to the film, Zach’s brother, Jacob Carson; father, Paul; 

mother, Robera; Charm City Cakes’ Duff Goldman and Mary Alice Yeskey; Carell; Charm 

City Cakes’ Geoff Manthorne; and Carell’s, actress Nancy Walls, celebrated the event 

with a “Get Smart”–inspired phone booth cake. 

stepped in with a combined gift of more than $1 million to create the Endowed 

Fund for Adolescent and Young Adult Psychosocial Oncology at Dana-Farber. 

A holistic approach 

Susan Block, MD, chair of the new Department of Psychosocial Oncology and 

Palliative Care at DFCI, will oversee the new fund, which will provide emotional 

support and education to AYA patients, addressing their concerns about fertility, 

lifestyle, sexuality and body image, insurance, exercise, and nutrition. It will 

assist patients in developing strategies for talking about cancer at school or in the 

workplace, communicating with family and friends, and, for young adults who 

are parents, finding ways to help their children understand the illness. 

The fund will provide resources for clinical programs, such as group therapy 

and support groups that connect AYA patients to peers with cancer, as well as 

individualized services for those struggling to cope or experiencing mental health 

issues. In addition to supporting the patients themselves, the new program will 

help parents of AYA patients with their own responses to a son’s or daughter’s 

cancer diagnosis, and aid them in finding ways to support their children at a 

time when, under normal circumstances, the adolescent or young adult would be 

forging an independent life. 

Since little is known about effective models of psychosocial care for the AYA 

population, the program will link research with clinical services. Building on 

the resources of the Institute’s Center for Psycho-oncology and Palliative Care 

Research, the impact of the clinical services will be systematically evaluated. 

This will allow the program to eliminate approaches that yield few results and to 

rapidly incorporate those that appear to improve outcomes. 

“The donors’ vision and extraordinary gift will help us to develop and 

disseminate a specialized program to address the unique challenges facing 

adolescents and young adults with cancer,” said Block. n 

This Holiday Season, Help Conquer Cancer 

Send our Cards, Candles, & Creations 

An evening of surprises for 

the Friends of Dana-Farber 

When the curtains closed on an evening of dinner, dancing, and fun 

after Surprise Party at Boston’s Wang Theatre in Boston May 30, 

$1 million had been raised to benefit the Friends of Dana-Farber 

Cancer Institute. 

The evening was hosted by Chairs Nina and David Fialkow and Vice Chairs 

Bill Karol, an Institute trustee, his wife, Sinesia, and Audrey and Mark Schuster. 

A cocktail hour in the lobby set the mood for the night as guests were treated 

to a performance by N’Kenge, famed opera and jazz singer, and a dazzling confetti 

shower as the theatre doors opened. 

Event Vice-chairs (left to right) Sinesia Karol and Institute Trustee Bill Karol, Chairs Nina and David Fialkow, 

and Vice-chairs Audrey and Mark Schuster share in the success of Surprise Party. 

Once guests were inside, Bill Karol shared his personal experience with cancer, 

and Bob Arnott, MD, described his time spent helping children with cancer as a 

field reporter for NBC News. The surprises continued when attendees played for 

great prizes in “The Big Game,” a live game show hosted by actor John O’Hurley 

of “Seinfeld” fame and host of “Family Feud.” 

The theater curtains then opened to reveal a spectacular setting for dinner on 

the stage; as they dined, attendees were entertained by a flamenco troupe and 

another stellar performance by N’Kenge. Following dinner, guests danced on the 

stage that was transformed into an edgy urban disco. 

“I am happy that Surprise Party was held to benefit the Friends,” said Nina 

Fialkow. “I am very impressed with this group that has grassroots beginnings and 

has now become a major supporter of DFCI.” 

Making Friends 

The Friends of Dana-Farber, an all-volunteer organization founded in 1976, raises 

funds to benefit patient care, support services, and education at the Institute. 

“On behalf of the Friends’ board, Co-president Lauren Frei and I are thrilled 

with the success of this event,” said Co-president Diane Flynn. “We are excited 

about the financial impact this evening is going to bring to research and care 

initiatives at the Institute.” 

Jean Canellos, honorary director of the Friends of Dana-Farber, a past Friends 

president, and cancer survivor, shared in this excitement. “Surprise Party is 

bursting forth with new energy that reflects the growth of the Institute, of the 

Friends organization, and the entire Boston and New England communities.” 

Since its inception, the Friends of Dana-Farber have raised $20 million for 

the Institute. n 

GPC Biotech Fellowship 

invigorates multiple 

myeloma research 

GPC Biotech is a biopharmaceutical 

company working to find effective 

treatments to combat cancer. 

Wishing to align itself with institutions 

that share similar missions, the company 

recently established the GPC Biotech 

Fellowship in Multiple Myeloma. This two-year, $150,000 fellowship will 

support Dana-Farber’s Diana Cirstea, MD, and her research into this incurable 

bone marrow cancer. 

The fellowship is overseen by Noopur Raje, MD, of the Jerome Lipper Center 

for Multiple Myeloma and LeBow Institute for Myeloma Therapeutics at DFCI, 

and director of Massachusetts General Hospital’s Center for Multiple Myeloma. 

“Dana-Farber is renowned for groundbreaking research and plays a vital role 

in finding new, effective treatments for patients with multiple myeloma,” said 

GPC Biotech’s Senior Vice President of Drug Development and Chief Medical 

Officer Martine George, MD. “We are pleased to make this contribution to 

support the excellent work of Drs. Cirstea and Raje.” 

Although the disease carries a low survival rate, a combination of conventional 

and targeted drugs have significantly prolonged and improved the lives of 

multiple myeloma patients. 

“The GPC Biotech Fellowship will facilitate research into the development 

of agents that are critical to changing patient outcomes,” explained Raje. One 

of the agents being explored is GPC Biotech’s kinase inhibitor RGB-286638, a 

novel compound targeting an important pathway relevant to myeloma that is 

in development. 

“This promising inhibitor has the potential to provide for the design of future 

clinical testing that combines this with other inhibitors, creating treatments that 

will ultimately make a positive difference for our patients,” added Cirstea. n 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Get involved 

with the JIMMY FUND in your area 

Join a Jimmy Fund Council in your community. Plan and 

participate in inspirational fundraising events while helping 

to spread the word about the Institute’s lifesaving mission. 

VIEW AND ORDER FROM OUR SELECTION OF CARDS, CANDLES, ORNAMENTS, AND APPAREL AT 

danafarber.org/holiday or call 617-632-5344 for a full brochure. 

All proceeds will benefit Dana-Farber’s lifesaving mission. 

Berkshire County, Greater Boston, R.I./Southeastern Mass., Western Mass. 

For more information, contact Janet Caparoso, Regional Director, the Jimmy Fund 

Western New England, at 888-546-6938 or visit jimmyfund.org/jfcouncils 

BOSTON_4.6528x8.3611_MAG_KTTC.indd 1 

7/30/08 5:12:25 PM 



Get involved, have fun, and beat cancer at jimmyfund.org. 

Sherwoods honor loved one 

with multiple myeloma support 

Emily Sherwood intimately understands the devastating toll of cancer, as her 

sister, Daryl Layzer, battled multiple myeloma for four years. Layzer had 

enrolled in a groundbreaking clinical trial led by Kenneth Anderson, MD, 

director of the Jerome Lipper Center for Multiple Myeloma and LeBow Institute 

for Myeloma Therapeutics at Dana-Farber. At that time, the trial offered the 

most promising treatment for 

Layzer’s disease. 

“From the beginning, Daryl 

received such excellent care at 

Dana-Farber,” recalled Sherwood. 

“Our feeling has always been that 

we wanted to give back, particularly 

to Dr. Anderson and his staff.” 

Sherwood and her husband, 

Ned, recently gave $131,000 to 

expand the Daryl E. Layzer Fund, 

which they established in Daryl’s 

memory with support from her 

mother and husband in 1998. 

The Sherwoods, both members of 

DFCI’s Hematologic Oncology 

Visiting Committee, hope that 

multiple myeloma patients 

continue to experience the same 

compassionate care that Daryl 

Kenneth Anderson, MD, continues to search for 

new agents and drug combinations to treat received, and that their gift propels 

multiple myeloma. 

Anderson’s efforts to develop 

new treatments. 

“It is so uplifting to hear the advances Dr. Anderson’s team has made,” added 

Sherwood. “We hope there will be a day when they tell us they’ve discovered the cure.” 

“The past support of Daryl’s family was critical in bringing new myeloma 

drugs, such as bortezomib and lenalidomide, from the bench to the bedside,” said 

Anderson, also the Kraft Family Professor of Medicine at Harvard Medical School. 

“This latest gift enables us to develop new drug combinations and devise strategies 

to reduce toxicity and block drug resistance in patients.” n 

Gala guests help to eradicate 

rare blood cancer 

Damon Runyon Cancer Research 

Foundation paves way for 

cancer-signaling roadmap 

The Damon Runyon Cancer 

Research Foundation has 

been a leader in fueling 

the cutting-edge work of upand-coming 

cancer investigators 

for more than 60 years. Now, 

the foundation is continuing its 

longstanding tradition by giving 

$450,000 to Dana-Farber’s 

Nathanael Gray, PhD, as part of 

its new Damon Runyon-Rachleff 

Innovation Award. 

Out of 425 applicants, Gray is 

one of only three scientists in the 

U.S. to receive the honor, which 

is supported by veteran Silicon 

Valley venture capitalist Andrew 

Rachleff and his wife, Debbie. 

DFCI’s Nathanael Gray, PhD, is one of three cancer 

investigators in the U.S. to receive the Damon 

Runyon-Rachleff Innovation Award. 

“It is difficult for young researchers to compete for grants from the National 

Institutes of Health, which are typically awarded to already proven research,” 

said foundation Executive Director Lorraine Egan. “These awards are designed 

to encourage early-career investigators to take chances on bold, new ideas in the 

hopes of making breakthrough discoveries.” 

With his award, Gray seeks to build a cancer-signaling roadmap that will track 

the chemical messages sent out by a class of proteins called kinases that, when 

mutated, can contribute to cancer growth. He believes that identifying these 

abnormal signaling pathways in cancer cells may, one day, lead to the discovery of 

novel, targeted patient therapies for many forms of cancer. 

“Scientific breakthroughs often come through collaboration outside an 

immediate field,” said Gray. “Unique funding opportunities, like the Damon 

Runyon-Rachleff Innovation Award, encourage the kind of creative thinking that 

leads investigators to these discoveries.” n 

You don’t have to be a doctor 

to cure cancer.SM 

INCLUDE DANA-FARBER CANCER INSTITUTE 

AS A BENEFICIARY OF YOUR WILL OR TRUST. 

Establish a bequest to benefit Dana-Farber 

and support this top-ranked national cancer 

center in its lifesaving mission. Make a 

positive, lasting impact on the lives of 

cancer patients everywhere. 

Generosity happens 

in the workplace 

In the last several years, companies have increasingly offered and encouraged 

their employees to contribute to charities through workplace giving programs 

in an effort to increase philanthropy and raise awareness about important issues, 

such as cancer. 

This trend has yielded tremendous results for non-profit organizations across 

the globe. In 2008, more than 200 firms in the U.S. gave more than $800,000 

through DFCI’s Companies for Cures program. These funds fuel Dana-Farber 

physician-scientists as they lead groundbreaking research efforts and offer 

innovative therapies and hope to patients around the world. 

IBM Corporation, which has given to DFCI through its workplace giving 

program since 2000, made it easy 

for employees and retirees to give 

to non-profits, like the Institute, 

via payroll deductions, one-time 

gifts, or gifts of stock. The company 

also provided a flexible method for 

employees to give a larger amount by 

spreading payments out over time. 

“Dana-Farber is consistently 

ranked one of the most popular 

charities for IBM employees 

to support in this region,” said 

Cathleen Finn, New England 

program manager of IBM 

Corporate Citizenship and 

Corporate Affairs. “Our employees 

feel good knowing that they are 

helping an important mission in the 

fight against cancer.” 

To learn more about DFCI’s 

Companies for Cures and how your 

company can get involved, contact 

Mary Bucci at 617-632-3146 or visit 

jimmyfund.org/workplacegiving.n 

Burger King honored for its 

fight against cancer 

Dana-Farber’s Companies for Cures program allows 

firms like IBM Corporation and its employees to make 

a combined impact on the Institute’s groundbreaking 

research and care initiatives. 

Rally Against Cancer SM 

hits grand slam 

More than 400 companies, 100 schools, and thousands of Boston Red 

Sox fans across New England collectively contributed more than 

$500,000 toward cancer care and research initiatives at Dana-Farber 

while taking part in the Jimmy Fund’s third annual Rally Against Cancer SM . 

Rally participants from companies and schools formed teams to compete to 

Rally Against Cancer Red Sox spokesplayer Dustin Pedroia (center) congratulates John Hancock Long 

Term Care employees (left to right) Martin Sheerin, Rally team captain Charlie Griffin, President 

Marianne Harrison, and Laura Wooster. 

raise the most money and win a visit 

from Boston Red Sox second baseman 

and 2008 Rally spokesplayer 

Dustin Pedroia. By contributing $5 

or more, each team member earned 

the right to wear Sox apparel to their 

office or classroom on April 8 in 

honor of the Red Sox home opener 

against the Detroit Tigers. 

Essex Elementary School in 

Essex, Mass., which raised $37,741, 

and John Hancock Long Term Care 

in Boston, Mass., which raised 

$19,060, were the winning teams 

and both enjoyed May 16 visits from 

Pedroia, who congratulated them for 

their efforts. 

“I’ve been to Dana-Farber and 

seen firsthand how overwhelming 

and life-altering cancer can be for 

families and patients,” said Pedroia. 

“Rally Against Cancer is an easy and 

fun way for everyone to help the 

Jimmy Fund, ultimately giving hope 

to the people who are fighting this 

awful disease.” n 

Red Sox second baseman Dustin Pedroia receives a warm 

smile from Essex Elementary school student Ollie Tolo. 

The Boston Red Sox Jimmy Fund Award is presented annually to individuals and 

organizations who have made longstanding commitments to support the lifesaving 

mission of Dana-Farber and the Jimmy Fund. On July 28, this honor was given to the 

Burger King Corporation and its franchises in recognition of the restaurant chain’s 

steadfast support of Dana-Farber through the A Chance for Kids promotion card 

program, which has raised more than $8 million for pediatric care and research since 

its inception in 2000. 

Defeat Cancer. 

Give at Work. 

Hundreds of guests turned out for the second annual Reaching for a Cure Gala, 

which supported multiple myeloma research at Dana-Farber. Held May 2 at the 

Westin Boston Waterfront in Boston, the event featured an elegant evening of dinner 

and dancing, and exciting live and silent auctions that included priceless sports 

memorabilia, a day with “Law and Order: SVU” star Mariska Hargitay, Caribbean 

vacations, and more. Gala attendees also had the opportunity to pose with the 2004 

and 2007 Boston Red Sox World Series trophies. 

Support our Lifesaving Mission by: 

Reaching for a Cure was founded in 2006 by the friends and family of Paul Stepanian, 

a multiple myeloma patient at Dana-Farber who was treated at Dana-Farber and is 

now in remission. Above: Stepanian enjoys the gala with his wife and event organizer, 

Julie (right), co-organizer Stephanie Farrohi (far left), and her daughter, Alexandra. 

To start making your plans today, please contact: 

Christopher E. Painter, Director of Gift Planning 

Phone: 617-632-3756 or 800-535-5577 

E-mail: Christopher_Painter@dfci.harvard.edu 

dana-farber.org/bequests 

Above: In a special on-field ceremony at Fenway Park in Boston, Red Sox CEO and 

President, Institute Trustee, and Mission Possible Campaign Co-chair Larry Lucchino 

(right of center) and Jimmy Fund Director Suzanne Fountain (far left) presented the 

award to Burger King franchisees and corporate representatives (left to right) Jim Joy, 

Josh Wyman, Jim Froio, Melissa Janikies, Larry Kohler, and John Janikies. 

• Setting up a workplace giving program in your place of employment 

• Giving to Dana-Farber through your company’s United Way Campaign 

• Inviting your company to “match” your gift 

Learn more at jimmyfund.org/workplacegiving 

or call Mary Bucci at 617-632-3146. 



Leave a legacy. Visit dana-farber.org/giftplanning to learn how. 

“ 

Samis Fund to support “a team 

that radiates with passion” 

Before I came to Dana-Farber for treatment, I had done extensive research 

on radiation oncology for prostate cancer, and the name Anthony D’Amico 

kept coming up,” said Mike Samis, a resident of Oklahoma City, Okla. “I 

soon found out why. I have never been around people with the kind of focus and 

passion that I saw in Dr. D’Amico and his staff. They are absolutely committed to 

eradicating prostate cancer.” 

Inspired by this dedication, 

Samis and his wife contributed 

$250,000 to establish the Karen 

and Michael Samis Family Prostate 

Cancer Research Fund under the 

direction of Anthony D’Amico, 

MD, PhD, who is chief of 

Genitourinary Radiation Oncology 

at Dana-Farber Cancer Institute and 

Brigham and Women’s Hospital. 

“The gift will be used to 

elucidate the relationship between 

the use of hormonal therapy to 

treat prostate cancer and its effect 

Mike and Karen Samis (far right), with daughters Carter and her 

fiancée, Fred Fellers (center), and Katharine and her fiancée, on a patient’s overall health,” 

Kent Regens, “want to participate in a small way and to push explained D’Amico. 

promising prostate cancer research along.” 

D’Amico has gained 

international attention for his work 

in the detection, staging, and treatment of prostate cancer, a disease that will 

be diagnosed in 186,000 men in the United States this year and claim the lives 

of nearly 29,000. In addition to treating patients, he is also a mentor to young, 

talented physician-scientists who work in his clinic. The Samis Fund will allow 

D’Amico’s team to spend more time on innovative, promising studies. 

“This very generous gift supports research by building the careers of our young 

men and women who are performing these studies,” added D’Amico. He believes 

it continues Dana-Farber’s tradition of training and supporting exceptional 

individuals who will become the next generation of cancer researchers. n 

Music of the heart 

Dana-Farber supporters and music lovers alike found their interests in harmony 

during “Tezz Yancey’s Rhythmic Journey,” an hour-long, melodic program created 

to benefit the Leonard P. Zakim Center for Integrative Therapies. Held May 8 at the 

Cutler Majestic Theatre in Boston, the show featured Yancey, an accomplished singer, 

dancer, and actor, and his company of performers taking the audience of nearly 

200 on a lively journey through different eras of music, from jazz and swing to rock, 

disco, and funk. 

At right: Following the inspiring performance, the event committee members 

celebrated the more than $100,000 raised to benefit the Zakim Center’s mission to 

provide Institute patients with therapies—such as massage and acupuncture—that 

complement more traditional forms of treatment. 

Early detection project 

launched by Karp family 

and H. H. & M. Metals, Inc. 

Cancer-screening tests enable physicians to detect certain cancers in their 

early stages, which can dramatically improve survival. Screening tests are 

particularly helpful for individuals considered at high risk, such as those with 

a family history of cancer. 

Recently, the Karp family—Harvey 

and Jean Karp, Harvey’s brother, 

Michael, and sister-in-law, Charlene 

Karp—contributed $250,000 to the 

Karp Family/H. H. & M. Metals, Inc. 

Fund for Cancer Research at Dana- 

Farber. The Karps’ gift will launch a 

pancreatic cancer-screening project led 

by Sapna Syngal, MD, MPH, director 

of Gastroenterology and the Familial 

Gastrointestinal Cancer Program at 

Dana-Farber/Brigham and Women’s 

Cancer Center. 

Sapna Syngal, MD, MPH, will utilize CT scan, 

“Cancer is prevalent in so many MRI, and endoscopic ultrasound technology to 

families, and my hope is that people screen high-risk individuals for pancreatic cancer. 

understand the importance of testing,” 

said Jean Karp, a colon cancer survivor with a family history of cancer. “Patient 

screening for pancreatic cancer is an area that particularly needs a lot of support.” 

In the U.S., pancreatic cancer is the fourth leading cause of cancer-related 

deaths in males and the fifth in females. The disease’s early stages are often without 

symptoms, so patients are typically diagnosed at an advanced stage, which 

contributes to high mortality rates. Syngal’s team aims to combat this through 

improved detection. 

“Our study will help identify many patients with early-stage lesions that may 

progress to pancreatic cancer while evaluating detection methods that may be 

applicable to many populations,” said Syngal. “Initial support from the Karp family 

allowed us to conduct critical pilot work, and their recent gift enables us to fully 

launch this important endeavor.” n 

SAY “I DO” 

Markin gift elevates support for Yawkey Center for Cancer Care 

As members of Dana-Farber’s community of supporters in Palm Beach, 

Fla., David Markin and his wife, Tracy, knew they wanted to support 

Mission Possible: The Dana-Farber Campaign to Conquer Cancer. Their 

family, like so many others, has been affected by cancer, and the Markins 

were impressed by the Institute’s focus on high-level patient care and research. 

Compelled to make a gift to DFCI, the Markins have given $500,000 in support 

of the new Yawkey Center for Cancer Care, a key funding priority of the 

$1 billion comprehensive capital campaign. 

Designed around Dana-Farber’s core principles of compassionate, comprehensive 

care and cutting-edge clinical research, the 13-story, 275,000-square-foot 

Yawkey Center will house 100 exam rooms and 150 infusion chairs to accommodate 

the needs of Dana-Farber’s expanding patient population. The state-of-the-art 

patient care facility is being designed as an environmentally friendly “green” 

building and is on schedule to open its doors in 2011. 

With their gift, the Markins have chosen to name an elevator bank on one of 

the clinical floors where patients will go for exams, infusions, and consultations 

with their Institute caregivers. 

“We felt this was a great way to make a public show of support for Dana-Farber 

in the hope that it would compel others to be excited about giving,” said David 

Markin. “We feel that Dana-Farber’s mission deserves others’ support and respect. 

“Tracy and I hope that one day cancer will be treated as a curable and 

controllable disease,” he further explained. “In the future, when patients are 

diagnosed, I hope to see a cure for even the types of cancers that right now have a 

low probability for survival.” n 

A wise investment: 

Malkiel’s CGA advances 

breast cancer research 

Like all good investors, Julian Malkiel likes to see his dollars put to use. It 

was this financial savvy that influenced his recent decision to establish a 

$250,000 Charitable Gift Annuity (CGA) at Dana-Farber. With an 8.5 

percent return, Malkiel’s CGA offers substantial tax benefits —including an 

immediate tax deduction and partial tax-free earnings—which explains why 

this is the third CGA he has established at Dana-Farber. Furthermore, his gift 

advances breast cancer research at the Institute—a battle close to his heart as his 

wife, Doris, passed away from the 

disease in 1997. 

“I have confidence that Dana- 

Farber is the kind of place that could 

put my money to good work,” said 

Malkiel. “I receive a number of 

solicitations from other institutions 

where I feel my gift would not go very 

far. At Dana-Farber, I know it does.” 

Though he now resides in Juno 

Beach, Fla., Malkiel and his late wife 

spent much of their lives in Stowe, Vt., 

and were familiar with Dana-Farber’s 

mission to conquer cancer, often 

participating in Jimmy Fund Golf 

tournaments. 

“This is a special way for me to 

honor my wife and further breast 

cancer research by investing in an 

Doris and Julian Malkiel’s longtime involvement with 

the Jimmy Fund has compelled Julian to establish three 

Charitable Gift Annuities (CGAs) at DFCI. 

organization we both admired and 

that is also located in New England,” 

explained Malkiel. n 

Tracy and David Markin hope that their gift to the Yawkey Center for Cancer Care will inspire others to 

support the Institute. 

Creating a lasting legacy 

through charity 

Advancements in cancer care and research by Dana-Farber’s physician-scientists are 

made possible thanks to the generosity and foresight of the members of the Dana- 

Farber Society, which welcomes those who have included the Institute in their estate 

plans. The longstanding tradition of honoring this loyal group of donors, who have 

already provided more than $80 million to DFCI since 1989, continued May 14 with 

the 18th annual Dana-Farber Society Recognition Dinner. 

Society Co-chairs M. Dozier Gardner, an Institute trustee, and his wife, Sandy (above), and 

DFCI President and CEO Edward J. Benz Jr., MD, welcomed 150 guests to The Charles 

Hotel in Cambridge, Mass., for the event. Attendees had the opportunity to hear remarks 

from Chief Scientific Officer Barrett J. Rollins, MD, PhD, who spoke poignantly about the 

role of stem cell research in the fight against cancer. 

For more information about the Dana-Farber Society and how to include the Institute 

in your estate plans, please visit dana-farber.org/society or call 800-535-5577. 

Choose among our elegant selection of wedding favors or personalize 

your own to inform guests that you have made a gift in their honor to 

support the lifesaving mission of Dana-Farber and the Jimmy Fund. 

Invest in cures for cancer. 

ESTABLISH A CHARITABLE GIFT ANNUITY (CGA) AT DANA-FARBER. RECEIVE SECURE RETURNS 

ON YOUR MONEY WHILE YOU SECURE ADVANCES IN CANCER RESEARCH AND CARE. 

View and order your favors online at jimmyfund.org/favors or 

contact Mary Bucci at 617-632-6099 or JFFavors@dfci.harvard.edu. 

Get started today. Contact: Christopher Painter, Director of Gift Planning 

Phone: 800-535-5577 or 617-632-3756 

E-mail: christopher_painter@dfci.harvard.edu 



Impact 

SUMMER 2008 

Non-profit Org. 

U.S. Postage 

PAID 

Dana-Farber 

Dana-Farber Cancer Institute 

Division of Development & The Jimmy Fund 

10 Brookline Place West, 6th Floor 

Brookline, MA 02445-7226 

ADDRESS SERVICE REQUESTED 

dana-farber.org and jimmyfund.org 

THANKING THOSE WHO MAKE A DIFFERENCE. 

Actor Steve Carell and his wife, actress Nancy Walls 

(right), mug for the camera with Nikki Dedekian 

during the second annual “A Premiere Cause” event, 

benefiting the Zachary Carson Brain Tumor Fund at 

Dana-Farber. (See related story on page 10). 

OCTOBER 

4 The World’s Sexiest Wines Dinner 15 

QVC Presents FFANY Shoes on Sale® 

25 

Joshua’s Run 

Treat yourself to the “world’s sexiest wines” and dine on delicious 

fare while supporting Dana-Farber Cancer Institute. Sponsored 

by the Wine Advocate Fund for Philanthropy, this fabulous event 

will be held at the residence of the Ambassador of France in 

Washington, D.C., and will be hosted by world-famous wine 

critic Robert Parker. For more information, contact Kimberly 

Chisholm at 617-632-5091 or visit wineadvocatefund.org. 

10,11 

12 

12 

An Evening with Champions 

Watch Olympic and world figure 

skating champions take to the ice 

with Harvard University skaters in an 

exhibition to benefit the Jimmy Fund. 

For more information on this 39th 

annual event, contact Harvard’s Eliot 

House at 617-493-8172 or 

ewc@hcs.harvard.edu. 

B.A.A. Half Marathon 

Race through Boston and Brookline’s 

Emerald Necklace park system on your 

way to the ultimate finish line: a world 

without cancer. Proceeds from this 

13.1-mile race support research and 

care at Dana-Farber. For more information, contact Mary Ann 

McChesney at 617-632-6915 or dfrunners@dfci.harvard.edu. 

Bank of America Chicago Marathon® 

Run Chicago to raise critical funds for Dana-Farber’s cancer 

research and care initiatives. For more information, contact Mary 

Ann McChesney at 617-632-6915 or dfrunners@dfci.harvard.edu. 

Shop thousands of designer and brand-name shoes at half the 

suggested retail price during the 15th annual Shoes on Sale. 

Presented by QVC and the Fashion Footwear Association of New 

York (FFANY), this event raises funds for breast cancer research 

at Dana-Farber and other national cancer centers. For more 

information, contact Kimberly Chisholm at 617-632-5091 or 

kimberly_chisholm@dfci.harvard.edu. 

16-19 

19 

Saks Fifth Avenue “Key To The Cure” 

Join the Friends of Dana-Farber and shop at Saks Fifth 

Avenue during its Key To The Cure shopping 

weekend. From Oct. 16 –19, Saks Fifth 

Avenue will contribute 

2 percent of all clothing sales 

to the Women’s Cancers 

Program at DFCI. For more 

information, contact Sarah 

Duggan at 617-632-3021 or 

sarah_duggan@dfci.harvard.edu. 

The Walk Against Breast Cancer 

Lace up your sneakers for the 

sixth annual walk through scenic 

Holliston, Mass., benefiting 

breast cancer research and 

patient care at Dana-Farber. 

For more information, e-mail 

hollistonwalksforbreastcancer@ 

comcast.net or visit 

hollistonwalks.org. 

Jog along the gorgeous cliffs of Scituate, Mass., while 

helping to fight pediatric cancers at Dana-Farber. The 12th 

annual Joshua’s Run features a 2-mile Fun Run/Walk and 

4-mile Road Race for adults, a Kids Fun Run, and the first annual 

Andrea’s Après Art Auction. For more information, contact Sarah 

Neukom at 617-632-5008 or visit joshuasrun.com. 

2 

NOVEMBER 

ING New York City Marathon® 

Dash through New York City in the world’s largest 

marathon while supporting the Institute’s mission to 

conquer cancer. For more information, contact Mary Ann 

McChesney at 617-632-6915 or dfrunners@dfci.harvard.edu. 

DECEMBER 

Dan Murphy’s Tree/Wreath Sales 

Participate in this 40-year-old holiday 

tradition and support the Jimmy Fund 

by purchasing your wreath or Christmas 

tree from the Murphy home, located at 

310 Highland Ave. in Randolph, Mass. 

Wreaths start at $6 and trees cost 

$20 – $50. For more information, call 

Dan Murphy at 781-963-5675 or visit 

jimmyfund.org/trees 

For more information on all Jimmy Fund and Dana-Farber events, go to jimmyfund.org or dana-farber.org.

Impact - The Jimmy Fund

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?